Skip to content

Multimodal Analgesia for the Reduction of Postoperative Opioid Consumption

Multimodal Analgesia for the Reduction of Postoperative Opioid Consumption

Status
Withdrawn
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03817034
Enrollment
0
Registered
2019-01-25
Start date
2021-03-11
Completion date
2021-03-11
Last updated
2021-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

multimodal, dexmedetomidine, ropivacaine, ketorolac, pain management, opioid sparing, analgesia

Brief summary

The investigators are performing this research study to investigate the efficacy of local infiltration of the surgical wound combining dexmedetomidine, ropivacaine, and ketorolac (treatment group) versus the current standard of care (historical control group), for post-operative pain management.

Detailed description

During this research study, patients recommended for a rectus sheath block during surgery will receive a novel combination of non-opioid drugs. Data from the treatment group will be compared to surgical outcomes of a historically matched control group to investigate the ability of this drug combination to reduce post-operative pain and post-operative opioid consumption.

Interventions

DRUGMultimodal analgesia

Subjects will be given a rectus sheath block containing dexmedetomidine, ropivacaine, and ketorolac

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Age greater than 18 years * American Society of Anesthesiologist Physical Status Classification 1-3 * Undergoing surgery requiring a rectus sheath block

Exclusion criteria

* American Society of Anesthesiologist Physical Status Classification of 4 or beyond * history of opiate of illicit substance abuse, chronic pain, or neurological dysfunction

Design outcomes

Primary

MeasureTime frameDescription
Change in post-operative opioid consumption48 hoursDecreased post-operative opioid consumption associated with use of multimodal analgesia
Change in post-operative pain scores48 hoursDecreased post-operative pain scores associated with use of multimodal analgesia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026